TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,313,166
|
1,148,383
|
2,224,055 |
| Earnings before taxes |
50,123
|
66,129
|
50,648 |
| Total assets |
564,178
|
539,402
|
1,103,206 |
| Current assets |
543,527
|
515,673
|
531,572 |
| Current liabilities |
295,601
|
326,499
|
308,315 |
| Equity capital |
260,199
|
210,522
|
692,400 |
| - share capital |
6,352
|
6,033
|
5,662 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.1%
|
39.0%
|
62.8% |
| Turnover per employee |
8,754
|
7,656
|
14,827 |
| Profit as a percentage of turnover |
3.8%
|
5.8%
|
2.3% |
| Return on assets (ROA) | |||
| Current ratio |
183.9%
|
157.9%
|
172.4% |
| Return on equity (ROE) |
19.3%
|
31.4%
|
7.3% |
| Change turnover |
104,084
|
-1,221,281
|
1,186,700 |
| Change turnover % |
9%
|
-52%
|
114% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.